Abstract: Evidence suggests that growth in providers' prices drives growth in health care spending on the privately insured. However, existing work has not systematically differentiated between the growth rate of hospital prices and that of physician prices. We analyzed growth in both types of prices for inpatient and hospital-based outpatient services using actual negotiated prices paid by insure...
HCCI will continue to analyze spending trends; Researchers will have HCCI data access until the end of 2022 The Health Care Cost Institute and United Healthcare are sunsetting their data collaboration relationship agreement, that has provided United's deidentified insurance claims data for analyses of U.S. healthcare spending, utilization, and market performance. HCCI continues to receive data fro...
HCCI's recent report on trends in rising insulin prices received additional media coverage in the last week in outlets including NBC, CBS, CNN, The New York Times, The Hill, U.S. News & World Report, and USA Today. From CNN: "Congress and the Trump administration continue to push for a drug pricing plan and were given more ammunition Tuesday in the form of a report documenting...
HCCI's latest research on rising insulin prices was recently featured in Reuters. HCCI's report detailed both use and price trends of insulin used by those with type 1 diabetes from 2012 to 2016. Per Reuters article: "A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that at $2,864 per patient in 2012, according to a...
HCCI's claims data was recently used to support investigations by Sarah Kliff into emergency room pricing in San Francisco. From Vox: "Data from the non-profit Health Care Cost Institute shows that the average price at other San Francisco-area emergency rooms is $2,000 — less than half the city hospital's price. "A privately insured patient does not seem to be getting a very good ...
